SESSION TITLE: Connective Tissue-Associated Interstitial Lung Disease
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Pulmonary fibrosis has been reported to occur in 25-90% of patients with systemic scleroderma with a lower prevalence of 12-39% in limited scleroderma. The cause of this fibrosis is presumed to be post-inflammatory. However, because of the presence of esophageal dysmotility in scleroderma, there is a possibility of aspiration resulting in fibrosis. If this were the case, the worse the esophageal dilatation, the more extensive would be the fibrosis. The objective of our study was to determine if there is a correlation between esophageal dilatation (measured by the esophageal diameter and extent of pulmonary fibrosis (estimated by fibrosis score from high resolution CT [HRCT] of chest) in patients with scleroderma.